Cargando…
Is it still worth pursuing the repurposing of metformin as a cancer therapeutic?
Over the past 15 years, there has been great interest in the potential to repurpose the diabetes drug, metformin, as a cancer treatment. However, despite considerable efforts being made to investigate its efficacy in a number of large randomised clinical trials in different tumour types, results hav...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10006178/ https://www.ncbi.nlm.nih.gov/pubmed/36823364 http://dx.doi.org/10.1038/s41416-023-02204-2 |